The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.
Sung-Il Cho, MD, ScD
Advertisement
Articles by Sung-Il Cho, MD, ScD
Advertisement
Latest Updated Articles
- Prescribing Trend of Pioglitazone After Safety Warning Release in Korea
November 19th 2019
Advertisement
Advertisement
Trending on AJMC
1
US Employer Health Care Costs Projected to Rise 9.5% in 2027
2
Rural Patients Face Gaps in Hospice Access, Care Intensity
3
5 Things to Know About Chronic Hand Eczema and Its Evolving Treatment Landscape
4
FDA Approves Nipocalimab-aahu as First Treatment for wAIHA
5